AdvaNan™ Nanoparticles

Each AdvaNan™ nanoparticle will contain a “vector molecule,” such as one or more selected monoclonal antibodies. Once injected into a patient, it will direct the AdvaNan™ nanoparticles to any type of cells or pathogens within the body that a practitioner wants to target (such as a virus, plaques, cancer cells, or cancer stem cells). Once there, the nanoparticles will attach themselves, along with any cargo they are carrying, to the target cells or pathogens. A component of AdvaNan™ contrast material makes it easy to see in an MRI scan, providing enhanced diagnosis and localization of targeted viruses, plaques, or tumor cells.